Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Exagen (XGN) Asset Utilization Ratio (2019 - 2025)

Historic Asset Utilization Ratio for Exagen (XGN) over the last 7 years, with Q3 2025 value amounting to 1.05.

  • Exagen's Asset Utilization Ratio fell 1282.41% to 1.05 in Q3 2025 from the same period last year, while for Sep 2025 it was 1.05, marking a year-over-year decrease of 1282.41%. This contributed to the annual value of 1.09 for FY2024, which is 4915.6% up from last year.
  • Exagen's Asset Utilization Ratio amounted to 1.05 in Q3 2025, which was down 1282.41% from 1.19 recorded in Q2 2025.
  • Exagen's Asset Utilization Ratio's 5-year high stood at 1.33 during Q1 2025, with a 5-year trough of 0.35 in Q2 2021.
  • In the last 5 years, Exagen's Asset Utilization Ratio had a median value of 0.74 in 2023 and averaged 0.76.
  • Per our database at Business Quant, Exagen's Asset Utilization Ratio crashed by 2746.2% in 2021 and then soared by 9673.74% in 2023.
  • Exagen's Asset Utilization Ratio (Quarter) stood at 0.38 in 2021, then grew by 26.18% to 0.49 in 2022, then skyrocketed by 83.77% to 0.89 in 2023, then surged by 41.36% to 1.26 in 2024, then fell by 16.99% to 1.05 in 2025.
  • Its Asset Utilization Ratio stands at 1.05 for Q3 2025, versus 1.19 for Q2 2025 and 1.33 for Q1 2025.